Japanese phase1 Study of Belimumab (IV vs SC)

Clinical trial NCT01516450 · COMPLETED

Trial details

NCT number: NCT01516450
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2011-12-26
Primary completion: 2012-04-11
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.